Skip to main content

Table 3 Influencing parameters for outcome, incremental cost and incremental cost effectiveness ratio (ICER) in the models

From: Cost effectiveness of pediatric pneumococcal conjugate vaccines: a comparative assessment of decision-making tools

Parameters

Outcomes

Incremental costs

ICER

 

DALY averted

QALY gained

    

Per DALY averted

Per QALY gained

 

TriVac (default)

TriVac (± 20%)

ADIP (± 20%)

SUPR (± 20%)

TriVac (default)

TriVac (± 20%)

ADIP (± 20%)

SUPR (± 20%)

TriVac (default)

TriVac (± 20%)

ADIP (± 20%)

SUPR (± 20%)

Population:

            

Total number of births per year

+

+

++

0

+

+

+++

++++

+

+

 

++

Life expectancy at birth

0

+

++

++

0

0

+

0

0

+

 

++

Under 5 years mortality per 1,000 live births

0

++

-

-

0

+

-

-

0

++

 

-

Burden of disease:

            

Incidence of pneumococcal pneumonia (per 100,000 per year)

++

++

++

-

+

+

++++

-

++

++

 

-

Incidence of meningitis (per 100,000 per year)

++

+

+

-

+

+

+

-

++

+

 

-

Incidence of invasive NPNM (per 100,000 per year)

++

++

+

-

+

+

+

-

++

++

 

-

Prevalence of bacteremia sp < 10 years (cases per year)

-

-

-

++

-

-

-

+

-

-

 

++

Case fatality rate of pneumococcal pneumonia

0

++

++

+

0

0

+

0

0

++

 

+

Case fatality rate of invasive NPNM

0

++

+

++

0

0

+

0

0

++

 

++

Vaccine information:

            

Vaccine efficacy of pneumococcal pneumonia

++

++

++

++

+

+

+

+

++

++

 

++

Vaccine efficacy of pneumococcal invasive NPNM

+

++

+

++

+

+

+

+

+

++

 

++

Vaccine efficacy adjusted NTHi

-

-

-

++

-

-

-

+

-

-

 

++

Vaccine coverage

+

+

++

++

+

++

++++

+++

+

+

 

++

Serotype coverage of pneumococcal pneumonia

+++

++

++

+

+

+

++++

+

+++

++

 

++

Number of doses

-

-

-

+

-

-

-

+++

-

-

 

+++

Dose cost

0

0

0

0

0

+++

++

+++

0

++

 

++

Other parameters:

            

Coverage 20 years after vaccine introduced (dose 1)

+

++

-

-

+

++

-

-

+

++

 

-

Coverage 20 years after vaccine introduced (dose 3)

+

++

-

-

+

++

-

-

+

++

 

-

GP visits < 10 years (AOM)

-

-

-

++

-

-

-

+

-

-

 

++

Proportion sp of AOM

      

-

 

-

-

 

++

Probability of death

-

-

-

++

-

-

-

0

-

-

 

++

  1. 0 = no change; - = not available; + = percentage change < 5%; ++ = percentage change 5% to 30%; +++ = percentage change 30% to 50%; ++++ = percentage change > 50%.
  2. AOM = acute otitis media; NPNM = non-pneumonia non-meningitis; NTHi = non-typeable Haemophilus influenza.
  3. ADIP = Pneumo ADIP; SUPR = Supremes